SYnAbs produces innovative monoclonal antibodies against poor immunogenic compounds and complex antigens. Targeting steroids, peptides, small molecules, toxins, lipids and polysaccharides (on fungi and bacteria), the company has developed strong expertise in immunology to break immunotolerance in rat and guinea pig species, generating monoclonal antibodies of high specificity and affinity. The antibodies are useful in the fields of hormones, toxins, autoimmune diseases and oncology.
Phone: 02 9698 2022
GAMA Healthcare Clinell Universal Wipes
The Therapeutic Goods Administration (TGA) has recognised that Clinell Universal Wipes, from GAMA...
Microbiologics SARS-CoV-2 whole virus and full process IVD controls
Microbiologics is launching IVD process controls and inactivated whole virus controls to meet the...
ViroStat Marburg virus monoclonal antibodies
ViroStat has released several monoclonal antibodies to the Marburg virus — one of the...
